Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Niagen Bioscience, Inc. (NAGE) had Debt to Equity Ratio of 0.00 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$99.60M |
|
$8.55M |
|
$38.01M |
|
$61.59M |
|
$91.87M |
|
$7.73M |
|
$1.13M |
|
$8.86M |
|
$8.86M |
|
$8.55M |
|
$8.55M |
|
$8.55M |
|
$8.55M |
|
$7.73M |
|
$8.54M |
|
75.93M |
|
78.12M |
|
$0.11 |
|
$0.11 |
|
| Balance Sheet Financials | |
$64.10M |
|
$1.72M |
|
$4.18M |
|
$68.28M |
|
$17.95M |
|
-- |
|
$4.24M |
|
$22.18M |
|
$46.09M |
|
$45.73M |
|
$46.09M |
|
77.33M |
|
| Cash Flow Statement Financials | |
$12.11M |
|
$-0.14M |
|
$5.37M |
|
$27.32M |
|
$44.66M |
|
$17.34M |
|
$3.66M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.57 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
0.00 |
61.84% |
|
7.76% |
|
7.76% |
|
8.57% |
|
8.89% |
|
8.58% |
|
$11.97M |
|
-- |
|
-- |
|
-- |
|
1.46 |
|
4.14 |
|
12.82 |
|
28.47 |
|
18.55% |
|
18.69% |
|
12.52% |
|
18.55% |
|
$0.60 |
|
$0.15 |
|
$0.15 |
|